National Institute of Diabetes and Digestive and Kidney Diseases; Notice of Closed Meeting, 39196-39197 [2020-14059]

Download as PDF 39196 Federal Register / Vol. 85, No. 126 / Tuesday, June 30, 2020 / Notices TOTAL ESTIMATED ANNUALIZED BURDEN—HOURS—Continued Number of respondents Form name Number of responses per respondent * Total responses ** Average burden per response (in hours) Total burden hours Heart Recipient Registration ................................................ Heart Follow Up (6 Month) .................................................. Heart Follow Up (1–5 Year) ................................................. Heart Follow Up (Post 5 Year) ............................................ Heart Post-Transplant Malignancy Form ............................. Lung Candidate Registration ............................................... Lung Recipient Registration ................................................. Lung Follow Up (6 Month) ................................................... Lung Follow Up (1–5 Year) ................................................. Lung Follow Up (Post 5 Year) ............................................. Lung Post-Transplant Malignancy Form .............................. Heart/Lung Candidate Registration ..................................... Heart/Lung Recipient Registration ....................................... Heart/Lung Follow Up (6 Month) ......................................... Heart/Lung Follow Up (1–5 Year) ........................................ Heart/Lung Follow Up (Post 5 Year) ................................... Heart/Lung Post-Transplant Malignancy Form .................... Liver Candidate Registration ............................................... Liver Recipient Registration ................................................. Liver Follow-up (6 Month–5 Year) ....................................... Liver Follow-up (Post 5 Year) .............................................. Liver Recipient Explant Pathology Form ............................. Liver Post-Transplant Malignancy ....................................... Intestine Candidate Registration .......................................... Intestine Recipient Registration ........................................... Intestine Follow Up (6 Month–5 Year) ................................. Intestine Follow Up (Post 5 Year) ....................................... Intestine Post-Transplant Malignancy Form ........................ Kidney Candidate Registration ............................................ Kidney Recipient Registration .............................................. Kidney Follow-Up (6 Month–5 Year) ................................... Kidney Follow-up (Post 5 Year) ........................................... Kidney Post-Transplant Malignancy Form ........................... Pancreas Candidate Registration ........................................ Pancreas Recipient Registration ......................................... Pancreas Follow-up (6 Month–5 Year) ................................ Pancreas Follow-up (Post 5 Year) ...................................... Pancreas Post-Transplant Malignancy Form ...................... Kidney/Pancreas Candidate Registration ............................ Kidney/Pancreas Recipient Registration ............................. Kidney/Pancreas Follow-up (6 Month–5 Year) .................... Kidney/Pancreas Follow-up (Post 5 Year) .......................... Kidney/Pancreas Post-Transplant Malignancy Form .......... VCA Candidate Registration ................................................ VCA Recipient Registration ................................................. VCA Recipient Follow Up .................................................... 140 140 140 140 140 71 71 71 71 71 71 69 69 69 69 69 69 146 146 146 146 146 146 20 20 20 20 20 237 237 237 237 237 133 133 133 133 133 133 133 133 133 133 27 27 27 24.3 22.0 90.6 154.0 12.8 45.2 35.7 32.4 118.8 116.5 19.7 1.0 0.5 0.4 1.1 3.3 0.3 90.3 56.5 266.6 316.6 10.6 16.3 7.0 5.2 26.2 37.2 2.1 168.8 89.4 431.9 449.4 22.6 2.8 1.5 7.9 15.9 0.7 9.8 7.7 32.8 57.8 2.2 0.9 1.6 0.7 3,406 3,082 12,686 21,556 1,788 3,210 2,532 2,297 8,438 8,271 1,400 67 32 31 79 228 21 13,183 8,256 38,919 46,225 1,544 2,387 139 104 524 744 42 39,998 21,195 102,350 106,507 5,365 368 194 1,047 2,119 97 1,297 1,028 4,363 7,688 292 24 43 18 1.2 0.4 0.9 0.5 0.9 0.9 1.2 0.5 1.1 0.6 0.4 1.1 1.3 0.8 1.1 0.6 0.4 0.8 1.2 1.0 0.5 0.6 0.8 1.3 1.8 1.5 0.4 1.0 0.8 1.2 0.9 0.5 0.8 0.6 1.2 0.5 0.5 0.6 0.6 1.2 0.5 0.6 0.4 0.4 1.3 1.0 4,087.2 1,232.8 11,417.4 10,778.0 1,609.2 2,889.0 3,038.4 1,148.5 9,281.8 4,962.6 560.0 73.7 41.6 24.8 86.9 136.8 8.4 10,546.4 9,907.2 38,919.0 23,112.5 926.4 1,909.6 180.7 187.2 786.0 297.6 42.0 31,998.4 25,434.0 92,115.0 53,253.5 4,292.0 220.8 232.8 523.5 1,059.5 58.2 778.2 1,233.6 2,181.5 4,612.8 116.8 9.6 55.9 18.0 Total .............................................................................. 6,204 ........................ 567,472 ........................ 425,925.1 * The Number of Responses per Respondent was calculated by dividing the Total Responses by the Number of Respondents and rounding to the nearest tenth. ** Numbers based on 2018 forms. Maria G. Button, Director, Executive Secretariat. DEPARTMENT OF HEALTH AND HUMAN SERVICES [FR Doc. 2020–14046 Filed 6–29–20; 8:45 am] National Institutes of Health khammond on DSKJM1Z7X2PROD with NOTICES BILLING CODE 4165–15–P National Institute of Diabetes and Digestive and Kidney Diseases; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting. VerDate Sep<11>2014 18:18 Jun 29, 2020 Jkt 250001 PO 00000 Frm 00037 Fmt 4703 Sfmt 4703 The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. E:\FR\FM\30JNN1.SGM 30JNN1 Federal Register / Vol. 85, No. 126 / Tuesday, June 30, 2020 / Notices Name of Committee: National Institute of Diabetes and Digestive and Kidney Diseases Special Emphasis Panel; Time-Sensitive Obesity. Date: July 29, 2020. Time: 1:00 p.m. to 2:30 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Two Democracy Plaza, 6707 Democracy Boulevard, Bethesda, MD 20892 (Video Meeting). Contact Person: Michele L. Barnard, Ph.D., Scientific Review Officer, Review Branch, Division of Extramural Activities, NIDDK, National Institutes of Health, Room 7353, 6707 Democracy Boulevard, Bethesda, MD 20892–2542, (301) 594–8898, barnardm@ extra.niddk.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.847, Diabetes, Endocrinology and Metabolic Research; 93.848, Digestive Diseases and Nutrition Research; 93.849, Kidney Diseases, Urology and Hematology Research, National Institutes of Health, HHS) Dated: June 25, 2020. Miguelina Perez, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2020–14059 Filed 6–29–20; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Center for Scientific Review; Notice of Closed Meetings khammond on DSKJM1Z7X2PROD with NOTICES Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Center for Scientific Review Special Emphasis Panel; RFA–RM– 20–003 Real-Time Chromatin Dynamics and Function. Date: July 9, 2020. Time: 1:00 p.m. to 2:30 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting). Contact Person: Charles Selden, Ph.D., Scientific Review Officer, Center for VerDate Sep<11>2014 18:18 Jun 29, 2020 Jkt 250001 Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 5187, MSC 7840, Bethesda, MD 20892, (301) 451– 3388. seldens@mail.nih.gov. This notice is being published less than 15 days prior to the meeting due to the timing limitations imposed by the review and funding cycle. Name of Committee: Center for Scientific Review Special Emphasis Panel; Member Conflict: Cognitive, Behavioral and Neuroimaging Signatures in Neurological Disorders. Date: July 23, 2020. Time: 8:30 a.m. to 6:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting). Contact Person: Seetha Bhagavan, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 5194, MSC 7846, Bethesda, MD 20892, (301) 237– 9838, bhagavas@csr.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel; PAR Panel: Mechanisms of Disparities in Lung Cancer. Date: July 23, 2020. Time: 11:00 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting). Contact Person: Kate Fothergill, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 3142, MSC 7770, Bethesda, MD 20892, (301) 435– 2309, fothergillke@mail.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel; Member Conflict: Emotions, Sleep, Stress, Health, and Psychopathology. Date: July 23, 2020. Time: 2:00 p.m. to 4:30 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892 (Telephone Conference Call). Contact Person: Katherine Colona Morasch, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 3170, MSC 7848, Bethesda, MD 20892, (301) 594– 9147 moraschkc@csr.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel; Molecular Immunology. Date: July 24, 2020. Time: 11:00 a.m. to 1:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting). Contact Person: David B Winter, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 4204, MSC 7812, Bethesda, MD 20892, (301) 435– 1152, dwinter@csr.nih.gov. PO 00000 Frm 00038 Fmt 4703 Sfmt 4703 39197 (Catalogue of Federal Domestic Assistance Program Nos. 93.306, Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 93.337, 93.393–93.396, 93.837–93.844, 93.846–93.878, 93.892, 93.893, National Institutes of Health, HHS) Dated: June 24, 2020. Miguelina Perez, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2020–14020 Filed 6–29–20; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Center for Scientific Review; Amended Notice of Meeting Notice is hereby given of a change in the meeting of the Center for Scientific Review Special Emphasis Panel, July 20, 2020, 11:00 a.m. to July 20, 2020, 04:00 p.m., National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD, 20892 which was published in the Federal Register on June 23, 2020, 85 FR 37684. This notice is being amended to change the meeting time from 11:00 a.m. to 4:00 p.m. to 12:15 p.m. to 5:00 p.m. The meeting is closed to the public. Dated: June 24, 2020. Ronald J. Livingston, Jr., Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2020–14021 Filed 6–29–20; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Office of the Director, National Institutes of Health; Notice of Meeting Pursuant to section 10(a) of the Federal Advisory Committee Act, as amended, notice is hereby given of a meeting of the NIH Clinical Center Research Hospital Board. The meeting will be held virtually and is open to the public. Individuals who plan to view the virtual meeting and need special assistance or other reasonable accommodations to view the meeting, should notify the Contact Person listed below in advance of the meeting. Name of Committee: NIH Clinical Center Research Hospital Board. Date: July 17, 2020. Time: 9:00 a.m. to 1:00 p.m. E:\FR\FM\30JNN1.SGM 30JNN1

Agencies

[Federal Register Volume 85, Number 126 (Tuesday, June 30, 2020)]
[Notices]
[Pages 39196-39197]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-14059]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Diabetes and Digestive and Kidney Diseases; 
Notice of Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.


[[Page 39197]]


    Name of Committee: National Institute of Diabetes and Digestive 
and Kidney Diseases Special Emphasis Panel; Time-Sensitive Obesity.
    Date: July 29, 2020.
    Time: 1:00 p.m. to 2:30 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Two Democracy Plaza, 6707 
Democracy Boulevard, Bethesda, MD 20892 (Video Meeting).
    Contact Person: Michele L. Barnard, Ph.D., Scientific Review 
Officer, Review Branch, Division of Extramural Activities, NIDDK, 
National Institutes of Health, Room 7353, 6707 Democracy Boulevard, 
Bethesda, MD 20892-2542, (301) 594-8898, 
[email protected].

(Catalogue of Federal Domestic Assistance Program Nos. 93.847, 
Diabetes, Endocrinology and Metabolic Research; 93.848, Digestive 
Diseases and Nutrition Research; 93.849, Kidney Diseases, Urology 
and Hematology Research, National Institutes of Health, HHS)

    Dated: June 25, 2020.
Miguelina Perez,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2020-14059 Filed 6-29-20; 8:45 am]
BILLING CODE 4140-01-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.